𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Substantia nigra hyperechogenicity in Parkinson’s disease

✍ Scribed by Edson Bor-Seng-Shu; Erich Talamoni Fonoff; Egberto Reis Barbosa; Manoel Jacobsen Teixeira

Book ID
106205094
Publisher
Springer Vienna
Year
2010
Tongue
English
Weight
133 KB
Volume
152
Category
Article
ISSN
0001-6268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transcranial imaging of substantia nigra
Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease
✍ Yu-Wen Huang; Jiann-Shing Jeng; Chung-Fen Tsai; Li-Ling Chen; Ruey-Meei Wu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract Transcranial Doppler imaging (TCDI) has been used as a noninvasive diagnostic tool to differentiate Parkinson's disease (PD) from atypical parkinsonism by detecting hyperechogenicity in the substantia nigra (SN). To our knowledge, no TCDI data are available for Asian populations, and TC

Substantia nigra hyperechogenicity as a
Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease
✍ Katherine J. Schweitzer; Rüdiger Hilker; Uwe Walter; Lothar Burghaus; Daniela Be 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Increased echogenic size (hyperechogenicity) of the substantia nigra (SN) is a characteristic transcranial sonography finding in patients with Parkinson's disease (PD). The SN echogenic size does not change in the course of the disease. In order to see whether this stable ultrasound mar

Five-year follow-up study of hyperechoge
Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
✍ Daniela Berg; Berthold Merz; Karlheinz Reiners; Markus Naumann; Georg Becker 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

## Abstract Using transcranial sonography, an area of hyperechogenicity at the substantia nigra (SN) may be detected as a typical marker in patients with Parkinson's disease (PD) as well as in approximately 9% of healthy subjects vulnerable to nigrostriatal impairment. In this longitudinal study, w